6tgg

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "6tgg" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6tgg is ON HOLD until Paper Publication
+
==scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar==
-
 
+
<StructureSection load='6tgg' size='340' side='right'caption='[[6tgg]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
-
Authors:
+
== Structural highlights ==
-
 
+
<table><tr><td colspan='2'>[[6tgg]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TGG OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6TGG FirstGlance]. <br>
-
Description:
+
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=N8W:~{N}-[(6~{S},7~{R},8~{S},8~{a}~{R})-7,8-bis(oxidanyl)-3-oxidanylidene-1,5,6,7,8,8~{a}-hexahydro-[1,3]oxazolo[3,4-a]pyridin-6-yl]ethanamide'>N8W</scene></td></tr>
-
[[Category: Unreleased Structures]]
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6tgg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tgg OCA], [http://pdbe.org/6tgg PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6tgg RCSB], [http://www.ebi.ac.uk/pdbsum/6tgg PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6tgg ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[[http://www.uniprot.org/uniprot/MUC1_HUMAN MUC1_HUMAN]] Note=MUC1/CA 15-3 is used as a serological clinical marker of breast cancer to monitor response to breast cancer treatment and disease recurrence (PubMed:20816948). Decreased levels over time may be indicative of a positive response to treatment. Conversely, increased levels may indicate disease progression. At an early stage disease, only 21% of patients exhibit high MUC1/CA 15-3 levels, that is why CA 15-3 is not a useful screening test. Most antibodies target the highly immunodominant core peptide domain of 20 amino acid (APDTRPAPGSTAPPAHGVTS) tandem repeats. Some antibodies recognize glycosylated epitopes.
 +
== Function ==
 +
[[http://www.uniprot.org/uniprot/MUC1_HUMAN MUC1_HUMAN]] The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack.<ref>PMID:9139698</ref> <ref>PMID:11877440</ref> <ref>PMID:14688481</ref> <ref>PMID:15710329</ref> <ref>PMID:16288032</ref> <ref>PMID:15513966</ref> <ref>PMID:17524503</ref> <ref>PMID:17308127</ref> <ref>PMID:16983337</ref> The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Regulates TP53-mediated transcription and determines cell fate in the genotoxic stress response. Binds, together with KLF4, the PE21 promoter element of TP53 and represses TP53 activity.<ref>PMID:9139698</ref> <ref>PMID:11877440</ref> <ref>PMID:14688481</ref> <ref>PMID:15710329</ref> <ref>PMID:16288032</ref> <ref>PMID:15513966</ref> <ref>PMID:17524503</ref> <ref>PMID:17308127</ref> <ref>PMID:16983337</ref>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Large Structures]]
 +
[[Category: Avenoza, A]]
 +
[[Category: Bermejo, I A]]
 +
[[Category: Bernardes, G J.L]]
 +
[[Category: Busto, J H]]
 +
[[Category: Castro-Lopez, J]]
 +
[[Category: Corzana, F]]
 +
[[Category: Garcia-Fernandez, J M]]
 +
[[Category: Garcia-Martin, F]]
 +
[[Category: Guerreiro, A]]
 +
[[Category: Hurtado-Guerrero, R]]
 +
[[Category: Navo, C D]]
 +
[[Category: Nishimura, S I]]
 +
[[Category: Ortiz-Mellet, C]]
 +
[[Category: Peregrina, J M]]
 +
[[Category: Samchez-Fernandez, E M]]
 +
[[Category: Anti cancer vaccine]]
 +
[[Category: Antibody]]
 +
[[Category: Antigen tn]]
 +
[[Category: Antitumor protein]]
 +
[[Category: Conformational analysis]]
 +
[[Category: Iminosugar]]
 +
[[Category: Scfv]]

Revision as of 06:55, 8 April 2020

scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar

PDB ID 6tgg

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/6tgg"
Personal tools